Our solution

Product Roadmap

At AI4CMR, our mission is to revolutionize CMR through advanced, AI-powered imaging solution. Our product roadmap reflects a strategic and phased approach to innovation, clinical integration, and global scalability in the field of Software as a Medical Device.

2019

Company Funded

Backed by Pathena VC
Company funded with a mission to revolutionize cardiac MRI through AI.
Core product vision: AI4CMR. an intelligent platform for automated cardiac MRI analysis

2020

AI4CMR v1.0

AI Module for cardiac function, performing segmentation and quantification of cardiac ventricles.
AI classification algorithm for global assessment of wall motion
First AI algorithms with IP Patent granted

2021

AI4CMR v1.0

Building cloud native solution compliant with patient data privacy, while being scalable and easy to access.
Built Interoperability Architecture
Additionally IP Patents granted
Secured Regulatory Clearances:
CE-Mark MDR (Class IIa – MDR 2017/745, EC Certificate # MDR 740464)

2022

AI4CMR v1.1

EIC Grant signed (Aug 2022, for €2.5M) ;
Contour editing computation service for live editing in cloud-based solution
Evidence Base for clinical validation of a fully automated framework for ventricular segmentation and wall motion classification from CMR.
Secured Regulatory Clearances:
FDA (510k Clearance # K220624)
UKCA (UKCA Certificate # UKCA 776320)

2023

AI4CMR v1.3

Communication Interface Protocol (enhanced DICOM interoperability)
Secured Regulatory Clearances:
SFDA Authorization MDMA*2*2023*1173
CDSCO Authorization IMP/MD/2024/000531